Navigation Links
Ben Shappley Joins Amedica's Leadership Team
Date:8/6/2009

SALT LAKE CITY, Aug. 6 /PRNewswire/ -- Amedica Corporation, a spinal and orthopaedic implant company focused on silicon nitride ceramic technologies, announced today that Ben Shappley has joined the Company as its Chief Executive Officer and President. Mr. Shappley will also serve on the company's Board of Directors.

Mr. Shappley has more than 25 years of orthopaedic and neurosurgical implant experience in both management and senior management roles. Most recently, he served as CEO and President of SpineMatrix. Prior to that, he was President of Theken Spine. Mr. Shappley has served in senior management positions in various companies including Therics Corporation, which was acquired by Theken Spine, Orthomatrix, Inc., Wright Medical Technology, Medtronic Sofamor Danek and Smith & Nephew. Mr. Shappley is a founding and charter member of the Institute for Orthopaedic Enlightenment and is a listed inventor on seven orthopaedic implant patents. Mr. Shappley holds a Bachelor of Science degree in Business Management.

"Our Board of Directors and Management team are pleased to extend a warm and enthusiastic welcome to Ben in his role at Amedica," said Max Link, Ph.D., Chairman of Amedica Corporation. "We believe his extensive experience in the spine and orthopaedic industries will provide significant skills to grow our spinal and orthopaedic implant business."

"It is my pleasure to welcome Ben to Amedica," said Ashok C. Khandkar, Ph.D., Vice Chairman of Amedica Corporation. "With Ben joining our team and leading operations and commercialization efforts, our business and technical leadership will be better positioned for success in the years ahead. This will free me to concentrate my efforts to developing and expanding Amedica's unique silicon nitride technology. I also look forward to devoting more time to broaden the portfolio of new and exciting products for the orthopaedic industry."

"I am pleased to be a part of Amedica, its significant and important technologies and successful management team. I believe that Amedica's advanced and heavily-patented silicon nitride ceramic technologies will play a continuing major role in cost-effective, improved spinal patient care," said Mr. Shappley.

About Amedica

Amedica Corporation is an emerging orthopaedic implant company focused on using its silicon nitride ceramic technologies to develop and commercialize a broad range of innovative, high-performance spine and joint implants for the growing orthopaedic device market. It has brought to market various spinal implant products, while products under development include reconstructive hip and knee implants that may represent a new standard of care in total joint implants based on superior disability performance and safety.


'/>"/>
SOURCE Amedica Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... a breakthrough topical cream that’s the first in a new class of photodynamic ... the overall appearance of skin, visibly reduce outward signs of aging, and minimize ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President Trump challenges ... for how his administration could impact the employee benefits industry. James Slotnick, AVP, ... most likely to make it through Congress. His discussion will focus on the ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... rely on contracted partners to help with process innovation in drug formulation and ... formulation experience along with state-of-the-art analytical equipment in support of their development and ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/24/2017)... ... April 24, 2017 , ... Emmanuel College is introducing ... advance their careers. Beginning in the fall of 2017, Emmanuel’s program will allow registered ... few as 16 months and for as little as $14,528. These changes will enable ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... India , April 19, 2017 ... and Application, Forecast to 2022 report has covered and analysed ... statistics and information on market size, shares and growth factors. ... major drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: